Electronic assessment of health-related quality of life in glioblastoma patients using the EORTC-QLQ-C30/EORTC-BN20 and the PROMIS system in clinical practice
Recommended Citation
Walbert T, Shin H, Schultz L, Nerenz D, Snyder JM, Mohn DJ. Electronic assessment of health-related quality of life in glioblastoma patients using the EORTC-QLQ-C30/EORTC-BN20 and the PROMIS system in clinical practice. Neurooncol Adv. 2026;8(1):055.
Document Type
Article
Publication Date
3-2-2026
Publication Title
Neurooncol Adv
Abstract
BACKGROUND: Patient-reported outcomes (PROs) are crucial for guiding patient care and maintaining quality of life This study assesses the feasibility of computer-based adaptations of the Patient-Reported Outcomes Measurement Information System (PROMIS) in a clinical setting and compares its outcomes with the EORTC-QLQ-C30 and EORTC-BN20 questionnaires. Validated, modular computer adaptive testing might reduce patient survey burden and provide physicians with more precise PROs.
METHODS: Newly diagnosed glioblastoma (GBM) patients were prospectively enrolled prior to radiation to evaluate feasibility. PROMIS modules were selected to reflect EORTC-QLQ-C30 and EORTC-BN20 domains, including anxiety, depression, fatigue, physical function, sleep disturbance, social satisfaction, cognitive ability, and global health. Patients completed both EORTC and PROMIS questionnaires electronically, preceding descriptive analyses.
RESULTS: Forty-three patients with 124 responses were analyzed. 31 patients completed surveys before or within 14 days of radiation, and 12 were outside the radiation window, yielding 60 completed surveys. Median completion times for the EORTC-QLQ-C30 and EORTC-BN20 were 4.77 (range: 2.05-18.6) and 2.63 (range: 1.17-24.83) min, respectively. For most PROMIS modules, completion times ranged from 0.6 to 1 min (range: 0.15-7.77), while global health took a median of 2.35 min (range: 1.02-21.12), The average time to completion was 8.65 min (range: 3.32-66.01). For most variables, PROMIS and EORTC-QLQ-C30 showed strong to moderate correlations.
CONCLUSIONS: PROMIS measures correlated well with EORTC instruments, making them a suitable tool for evaluating patients with GBM. Response times were generally short, but variability suggested that low computer literacy, limited internet access, and disease burden may affect involvement.
PubMed ID
42011289
Volume
8
Issue
1
First Page
055
Last Page
055
